JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 2, 2006; DOI: 10.1124/jpet.106.115212


0022-3565/07/3202-544-551$20.00
JPET 320:544-551, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.115212v1
320/2/544    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.

CARDIOVASCULAR

Dihydropyridines Inhibit Acetylcholine-Induced Hyperpolarization in Cochlear Artery via Blockade of Intermediate-Conductance Calcium-Activated Potassium Channels

Zhi-Gen Jiang, Xiao-Rui Shi, Bing-Cai Guan, Hui Zhao, and Yu-Qin Yang

Oregon Hearing Research Center, Oregon Health and Science University, Portland, Oregon (Z.-G.J., X.-R.S., B.-C.G., H.Z., Y.-Q.Y.); and Department of Otolaryngology, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, People's Republic of China (H.Z.)

Received October 8, 2006; accepted October 31, 2006.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Acetylcholine (ACh) induces hyperpolarization and dilation in a variety of blood vessels, including the cochlear spiral modiolar artery (SMA) via the endothelium-derived hyperpolarization factor (EDHF). We demonstrated previously that the ACh-induced hyperpolarization in the SMA originated in the endothelial cells (ECs) by activating a Ca2+-activated K+ channel (KCa); the hyperpolarization in smooth muscle cells was mainly an electrotonic spread via gap junction coupling. In the present study, using intracellular recording, immunohistology, and vascular diameter tracking techniques on in vitro SMA preparations, we found that 1) ACh-induced hyperpolarization was suppressed by intermediate-conductance KCa (IK) blockers clotrimazole (IC50 = 116 nM) and nitrendipine and by the calmodulin antagonist trifluoperazine, but it was not suppressed by the big-conductance KCa blocker iberiotoxin. The immunoreactivity to anti-SK4/IK1 antibody was localized mainly in ECs. 2) The three dihydropyridines—nifedipine, nitrendipine, and nimodipine—all concentration-dependently inhibited the ACh-induced hyperpolarization, with an IC50 value of 455, 34, and 3.2 nM, respectively. 3) Among other L-type Ca2+ channel (IL) blockers, 10 µM verapamil exerted a 20% inhibition on ACh-induced hyperpolarization, whereas diltiazem and the metal ion Ca2+ channel blockers Cd2+ and Ni2+ had no effect. 4) Nitrendipine and charybdotoxin abolished ACh-induced dilation in the SMA. We conclude that ACh-induced hyperpolarization in the SMA is generated mainly by activation of the IK in the ECs, and dihydropyridines suppress the EDHF-mediated hyperpolarization by blocking the IK channel, not the IL channel. The clinical relevance of this dihydropyridine action is discussed.


Several vasoactive agents, such as acetylcholine (ACh), substance P, and bradykinin, cause robust hyperpolarization and vasodilation when the endothelium is intact. The hyperpolarization and vasodilation have been attributed to endothelium-derived hyperpolarization factor (EDHF) or endothelium-derived relaxation factor (Faraci and Heistad, 1998Go; Busse et al., 2002Go). The EDHF is an important mechanism regulating blood flow to organs and tissues and is implicated in vascular pathology, such as ischemia, hypertension, atherosclerosis, diabetic and aging vascular malfunction (Faraci and Heistad, 1998Go), and coronary vascular spasms (Konidala and Gutterman, 2004Go).

The EDHF seems to be a variable combination of gap junction coupling, endothelial release of K+, NO, epoxyeicosatrienoic acids, and prostanoid in various vascular beds and in different animal species (Busse et al., 2002Go). We reported recently that ACh induced hyperpolarization and dilation in the cochlear spiral modiolar artery (SMA) via the EDHF (Jiang et al., 2005Go) and found that ACh-induced EDHF in the SMA was a complex. The induced hyperpolarization originated in the endothelial cell (EC) by activating Ca2+-activated K+ channels (KCas). ACh-induced hyperpolarization in smooth muscle cells (SMCs), however, was mainly (60%) an electrotonic spread of the hyperpolarization from the EC via gap junction coupling. The EC also released K+ into myoendothelial interlayer space via its activated KCa, which in turn activated the inward rectifier potassium channel (Kir) and Na+-K+-ATP pump current in the SMC. Nonetheless, activation of KCa in the EC plays a primary and essential role in the EDHF-mediated vasodilation in the SMA as well as in many other vascular beds.

According to single-channel conductance and pharmacological characteristics, three classes of KCas—big conductance, intermediate conductance, and small conductance (BK, IK, and SK)—are identified in the SMC and/or the EC (Nilius and Droogmans, 2001Go; Ledoux et al., 2006Go). Recent work has pointed to IK activation as the main electrogenesis mechanism of ACh-induced hyperpolarization in the EC (Coleman et al., 2001Go; Eichler et al., 2003Go; Ledoux et al., 2006Go). Therefore, it would be interesting to know whether the ACh-induced hyperpolarization in the SMA is sensitive to specific IK blockers or BK blockers.

In this respect, a dihydropyridine, nitrendipine, has been found to be a potent blocker for cloned human IK channel expressed in HEK-293 cells (Jensen et al., 1998Go). Dihydropyridines (DHPs) are widely used vasodilators for treating hypertension and angina by blocking L-type Ca2+ channels (IL) in vascular SMCs. It is therefore important to know whether nitrendipine and other DHPs effectively suppress the EDHF-mediated hyperpolarization. In addition, it would be interesting to know whether other classes of IL blockers verapamil (a benzothiazepine) and diltiazem (a phenylalkylamine), would affect the ACh-induced hyperpolarization. We report here that the three DHPs—nifedipine, nimodipine, and nitrendipine—share the IK-blocking property and suppress the ACh-induced hyperpolarization in the cochlear artery cells, whereas verapamil and diltiazem had little effect on the IK-mediated ACh-induced hyperpolarization. Preliminary data of this work has been published in a meeting abstract (Jiang et al., 2004Go).


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Animals and in Vitro Arterial Preparations. SMA segments were prepared as described previously (Jiang et al., 1999Go, 2005Go). Guinea pigs (250–500 g) were anesthetized by intramuscular injection of an anesthetic mixture (1 ml/kg) of 500 mg of ketamine, 20 mg of xylazine, and 10 mg of acepromazine in 8.5 ml of H2O and then killed by exsanguination. Both bullae were rapidly removed and transferred to a Petri dish filled with a physiological solution (Krebs') composed of 125 mM NaCl, 5 mM KCl, 1.6 mM CaCl2, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 20 mM NaHCO3, and 8.2 mM glucose, and saturated with 95% O2 and 5% CO2 at 35°C, pH 7.4. The SMA was dissected out from the cochlea under a stereomicroscope. The vessels were incubated for 0.5 to 24 h in the Krebs' solution and transferred to a recording bath for intracellular recording. The Oregon Health and Science University Animal Care and Use Committee approved the animal use procedure.

Intracellular Recording. A 2- to 5-mm-long segment of the SMA (40–80 µm in diameter) was pinned with minimal stretch to the silicon rubber layer (Sylgard 184; Dow Corning, Midland, MI) in the bottom of the recording bath (0.5-ml volume) and continuously superfused with a 35°C Krebs' solution. The outside connective tissues were cleaned manually under a stereomicroscope (Nikon SMZ-2T; Nikon, Tokyo, Japan). The glass microelectrode was filled with 2 M KCl with a tip resistance of 60 to 200 M{Omega}. Intracellular penetration was obtained by advancing the electrode into adventitial surface of the vessel with a micromanipulator (MP-1; Narishige, Tokyo, Japan). Transmembrane potential and current were simultaneously monitored with an NPI preamplifier (SEC10-LX; NPI, Tamm, Germany). The electrical signals were recorded with a computer equipped with pClamp9 software (Molecular Devices, Sunnyvale, CA) using sampling intervals of 0.1, 0.5, or 10 ms. The resting potential (RP) was usually determined 5 min after the initial voltage jump at penetration and checked by the voltage jump at the withdrawal of the electrode. The membrane input resistance was measured by applying 0.2- to 0.5-nA, 0.5- to 2-s current pulses via the recording electrode with the capacitance compensation and bridge-balance well adjusted on the NPI preamplifier (Jiang et al., 2001Go). The adjustment was achieved by concurrently using an additional data acquisition computer, a monitor displaying fast sweeps (0.5–2 s) of current-voltage signals at a 10-kHz sampling rate to ensure the best bridge-balance during the recording period (Jiang et al., 2005Go). In addition, five or 10 sweeps were averaged to reduce the baseline noise.

Drug Application and Statistics. Drugs in known concentrations were applied via a bath solution. The solution that passed the recording chamber could be switched, without change in flow rate and temperature, to a solution that contained a drug or a solution of different ionic composition. Drugs used in this study were ACh, charybdotoxin (ChTX), clotrimazole (CLT), (–)-cis-diltiazem (diltiazem), 4-diphenylacetoxy-N-methylpiperidine methiodide (DAMP), iberiotoxin (IbTX), nifedipine, nimodipine, nitrendipine, trifluoperazine (TFP), verapamil (all from Sigma/RBI, Natick, MA), and 18beta-glycyrrhetinic acid (18betaGA; MP Biomedicals, Irvine, CA). Statistical values are expressed as means ± S.E.M.

Immunohistochemistry of IK Channel. Albino guinea pigs (500~600 g) were anesthetized with an overdose of ketamine hydrochloride (100 mg/kg i.m.; Abbott Laboratories, Abbott Park, IL) and xylazine hydrochloride (2 mg/kg i.m.; Phoenix Scientific, Inc., St. Joseph, MO). Cochleae were taken after cardiovascular perfusion with saline followed by 4% paraformaldehyde and then immersed in the same fixative solution for 4 h. The SMA was dissected out from the cochlea, washed in 0.02 M PBS, pH 7.4, and then permeabilized in 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO) for 1 h. After immunoblock in 10% goat serum and 1% bovine serum albumin (BSA) in the PBS for 1 h, the specimens were incubated overnight in a solution containing anti-SK4/IK1 antibody (rabbit polyclonal antibody, SC-32949, 1:100 diluted with 1% BSA-PBS; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and anti-{alpha} smooth muscle actin antibody conjugated with Cy3 (monoclonal, C6198, 1:400 dilution; Sigma-Aldrich). Specimens were washed in 1% PBS for 30 min and incubated in Alexa Fluor 488 anti-rabbit IgG (1:100 diluted with 1% BSA-PBS; Invitrogen, Carlsbad, CA) for 1 h. After wash for 30 min, the vessels were mounted and observed on a Nikon Eclipse TE 300 inverted microscope equipped with a Bio-Rad MRC 1024 confocal laser scanning system (Bio-Rad, Hercules, CA). Negative controls were done by incubating the tissue with 1% BSA-PBS containing no anti-SK4/IK1 primary antibody.

Vessel Diameter Measurement. SMA diameter (outside edge to edge) was tracked by a videocamera and computer software as described previously (Jiang et al., 2003Go). In brief, the SMA segment in the bath was dark field-illuminated by a fiber optic lamp and imaged by a videocamera (Sony XC-13; Sony, Tokyo, Japan) through the trinocular stereomicroscope. The image of the SMA was displayed on a monitor, recorded on a VCR, and digitized by a video capture board (Matrox RainbowRunner Studio) in a Pentium III PC. The digitized video signal was processed online by customer-written edge-detection software. The digital sampling rate for the vessel diameter varied between 2 and 5 Hz. Through a D/A converter board, a voltage signal proportional to the diameter was fed to pClamp9 interface (Digidata 1322A. Molecular Devices) for digital recording (Fig. 6). The digitized images were also saved to disks for further analysis.


Figure 6
View larger version (27K):
[in this window]
[in a new window]

 
Fig. 6. ACh-induced vasodilation is sensitive to M3 antagonist, KCa channel blocker, and dihydropyridine. A to C, sample chart records show that ACh caused an increase in SMA diameter (dilation) in the majority of cases, and the dilation was nearly completely blocked by DAMP, ChTX, and nitrendipine. Nitrendipine, but not ChTX or DAMP, alone caused a small increase in the diameter. Note that in ChTX and nitrendipine, a transient vasoconstriction by ACh was unmasked after the blockade of the dilation in these cases.

 

    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
General Observations and ACh-Induced Hyperpolarization. Conventional intracellular recordings were made from segments of isolated SMA of either side. The membrane properties of the cells are similar to those reported previously (Jiang et al., 2001Go, 2005Go). In brief, the cells sampled usually showed an initial RP either near –40 or –75 mV, called low or high RP, respectively. A low RP cell may quickly shift its RP from the low level to the high level and vise versa (see Fig. 1A in Jiang et al., 2005Go). Roughly one-half of the recordings were from smooth muscle cells (SMCs), and one-half were from ECs (Jiang et al., 2001Go). The membrane properties of the SMC and the EC are generally indistinguishable (Jiang et al., 2001Go). In addition to single-cell labeling with propidium iodide-containing electrode and histological examination (Jiang et al., 2001Go), it was possible to determine the cell type during the intracellular recording by observing the effects of 30 µM18betaGA, a gap junction blocker, on the hyperpolarization induced by high 10 mM K+ and/or ACh (Jiang et al., 2005Go). The SMCs that had a low RP always showed a high K+-induced hyperpolarization (Fig. 1, A and B) that was not sensitive to 18betaGA, whereas they exhibited an ACh-induced hyperpolarization that was largely blocked by 18betaGA. Conversely, in the ECs with a low RP, high K+-induced hyperpolarization was blocked by 18betaGA, but the hyperpolarization response to ACh was not sensitive to 18betaGA. A portion of the cells in this study was identified for the cell type by one or both methods.


Figure 1
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 1. Nitrendipine, not IbTX, mimics ChTX in blocking ACh-induced hyperpolarization. A, traces show that ChTX suppressed the ACh-induced hyperpolarization but not 10 mM K+-induced hyperpolarization. One-hour wash-out of ChTX resulted in a partial recovery of the ACh-induced hyperpolarization. B, nitrendipine had similar effects. Note that when ChTX or nitrendipine blocked the ACh-induced hyperpolarization, a delayed depolarization was unmasked. C, traces show that IbTX had no effect on the ACh-induced hyperpolarization. A, B, and C were from different confirmed smooth muscle cells with resting potentials indicated on the left of control traces. Ba2+ (200 µM) was present throughout the experiments depicted in C but not in A and B. The voltage scale bar in C applies to all traces.

 
ACh (3 µM) caused a submaximal hyperpolarization (5–35 mV) in almost all the cells that had a low RP (–30 to –60 mV; Fig. 1, A and B) or in a cell that initially had a high RP but was depolarized to the low RP level by 100 to 200 µMBa2+ (Fig. 1C), but ACh always caused a depolarization in high RP cells (data not shown; Jiang et al., 2005Go). The hyperpolarization often had a variable fast transient phase lasting 10 to 30 s followed by a sustained phase lasting to wash-out of ACh (Fig. 2A). The two phases were sometimes separated by a narrow notch (Fig. 5A), or they merged as a single phase (Fig. 1). In many cells, a delayed depolarization was unmasked after the ACh-induced hyperpolarization was pharmacologically suppressed (Fig. 1, A and B). To quantify the ACh-induced hyperpolarization better, we always took the ACh-induced hyperpolarization amplitude at 80 s after the beginning of ACh application, to minimize the influence of the initial transient hyperpolarization and the unmasked depolarization. Unlike the ACh-induced hyperpolarization, the ACh-induced depolarization was insensitive to the KCa blocker 50 nM ChTX (data not shown; Jiang et al., 2005Go), suggesting that the two responses have different ionic mechanisms. We will report a study on the ACh depolarization separately and thus no further analysis was made in this report regarding the ACh depolarization. To avoid an unwanted membrane resting potential shift from a low RP to high RP (Jiang et al., 2001Go), which would sabotage the quantitative experiments of the ACh action, we kept 100 (occasionally 200) µMBa2+ present throughout all experiments except when otherwise stated. Because this concentration of Ba2+ eliminated the Kir implication in ACh-induced hyperpolarization in the SMCs (see Introduction; Jiang et al., 2005Go), it made the ACh-induced hyperpolarization in the SMC almost solely an electrotonic spread of the ACh-induced hyperpolarization of the EC. This largely unified the electrogenesis mechanism of the ACh-induced hyperpolarization in the SMC and the EC, so that the sensitivity of the ACh-induced hyperpolarization to relevant channel blockers became equalized between these two types of cells.


Figure 2
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 2. ACh-induced hyperpolarization is sensitive to IK channel blocker CLT and calmodulin antagonist TFP. A, sample traces show that 3 µM ACh-induced hyperpolarization was increasingly suppressed by increased concentrations (in micromolar) of CLT in an endothelial cell. B, concentration-response curve is fitted to data of four cells according to the Hill function y = 100/[1 + (x/Ki)h], revealing a Ki or IC50 value of 116 nM and a Hill number (h) of 0.82. The amplitude of ACh-induced hyperpolarizations in the presence of CLT was normalized to the control of each cell. Membrane potential was 41.2 ± 0.96 mV; control ACh-induced hyperpolarization was 23.9 ± 1.23 mV. C, trifluoperazine also concentration-dependently attenuated the ACh-induced hyperpolarization. Ba2+ (100 µM) was present throughout all the experiments depicted in A to C. Scale bars in C also apply to A.

 

Figure 5
View larger version (24K):
[in this window]
[in a new window]

 
Fig. 5. Dihydropyridine suppression of ACh-induced hyperpolarization is not mimicked by other calcium channel antagonists. A to E, representative traces show 3 µM ACh-induced hyperpolarization was almost completely suppressed by 10 µM nifedipine but only ~20% reduced by 10 µM verapamil and not significantly changed by 10 µM diltiazem, 100 µM Cd2+, or Ni2+. A to E were each from different cells. Ba2+ (100 µM) was present throughout the experiments. Scale bars in E apply to all traces. F, column graph shows the data of means and S.E. from the cell groups. Cd, Cd2+; Dilt, diltiazem; Ni, Ni2+; Verap, verapamil. Paired t test; **, p < 0.01. Sample size for each group is indicated near the error bars.

 

IK Mediates the ACh-Induced Hyperpolarization. We previously reported that the KCa activation is largely responsible for generation of the ACh-induced hyperpolarization in an EC of the SMA (Jiang et al., 2005Go), because the hyperpolarization was associated with an increase in input conductance, enhanced by membrane depolarization and blocked by ChTX (by 81%; Fig. 1A) plus apamine (by 10–20%) or 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, a membrane-permeable Ca2+ chelator, but not by Ba2+. To further identify the role of the IK, we tested the effects on the ACh-induced hyperpolarization of the known IK blockers nitrendipine and clotrimazole (Jensen et al., 1998Go) and a BK-selective blocker, IbTX (Van Renterghem et al., 1995Go). Figures 1 and 2 depict the main results. In contrast to a strong blockage by ChTX (Fig. 1A), ACh-induced hyperpolarization was not significantly altered by 100 nM IbTX (Fig. 1C; paired t test, p > 0.05; n = 3), consistent with a notion that the ACh-induced hyperpolarization is generated by an activation of IK, not BK (Ledoux et al., 2006Go). Similar to ChTX, IbTX alone caused a small (3- to 5-mV) depolarization in the majority of the cells tested (n = 10 and 4).

Nitrendipine (1 µM) suppressed the ACh-induced hyperpolarization by 95.2 ± 18.6% in all the cells tested (n = 7), whereas having no significant effect on the 10 mM K+-induced hyperpolarization (Fig. 1B), suggesting a specific IK blockade without affecting the Kir. Nitrendipine suppression of the ACh-induced hyperpolarization was partially reversible upon wash-out of the drug for longer than 30 min. The inhibition was not significantly different between the identified EC and SMC (Student's t test, p > 0.05; n = 6 and 9).

CLT, an antifungal antibiotic and known IK blocker, concentration-dependently suppressed the ACh-induced hyperpolarization (Fig. 2). A Hill equation fit to the concentration-inhibition relation of four cells revealed an IC50 of 116 nM and a Hill number of 0.82. The inhibition was partially reversible after a 20-min wash with CLT-free solution. Nitrendipine or CLT alone caused little change in the RP.

It is known that IK (or IK1, now termed SK4) belongs to SK protein family and that calmodulins join the SK subunits to form the SK channel polymer complex (Ledoux et al., 2006Go) where the calmodulin functions as the sensor of intracellular Ca2+. The calmodulin antagonist TFP (10 and 100 µM) caused a concentration-dependent inhibition of ACh-induced hyperpolarization in all cells tested (inhibited 30 ± 5.0 and 92 ± 2.7%, respectively; p < 0.01; n = 4; Fig. 2C). The inhibition was partially reversible after a 10-min wash-out. TFP alone in low concentration (10 µM) caused little change in the RP but induced a 1- to 8-mV depolarization when 100 µM was administrated.

Immunohistochemistry Identification of IK Expression in the SMA Cells. The IK channel protein in the SMA was detected by immunoreaction with anti-SK4/IK1 antibody in two adult guinea pigs tested. The IK immunoreactivity (tagged as green fluorescent color) was localized in all the ECs of the SMA tested (Fig. 3). The fluorescent signal of IK channel protein seemed evenly lined with the surface membrane of the ECs. In contrast, the IK signal was only faintly and unevenly observed in some smooth muscle cells, consistent with the electrophysiological data that the ACh-induced hyperpolarization is generated in the EC.


Figure 3
View larger version (22K):
[in this window]
[in a new window]

 
Fig. 3. Confocal images of immunolabeling of SK4/IK1 in the SMA of guinea pigs. All panels are single optic sections of ~1 µm. A, smooth muscle cells visualized by an antibody for {alpha}-smooth muscle actin (red). B, all the ECs had a strong SK4/IK1 immunoreactivity (green), especially on the surface of the cell (arrowheads), whereas the SMC layer displayed an intermittent and weak reactivity. C, merged image of A and B showing the relationship of endothelial cells and smooth muscle cells. D to F, results of negative control experiments. E, same procedures as for B except no primary antibody of SK4/IK1 was added for the reaction. Scale bar, 10 µm (in C and F), is for top and bottom rows, respectively.

 
Dihydropyridines Share the Property of IK Inhibition. The nitrendipine inhibition on ACh-induced hyperpolarization was concentration-dependent (Fig. 4A). The initial fast phase of the ACh-induced hyperpolarization was often only partially suppressed (Fig. 4A) when the sustained phase showed a complete blockade. Such a residual transient hyperpolarization was also often seen after application of 50 nM ChTX (Fig. 1A) or other DHPs (Fig. 4).


Figure 4
View larger version (20K):
[in this window]
[in a new window]

 
Fig. 4. Dihydropyridines concentration-dependently suppress ACh-induced hyperpolarization. A, sample traces depict that nifedipine (Nif), nimodipine (Nimo), and nitrendipine (Nitr) in micromolars all suppressed the 3 µM ACh-induced hyperpolarization more pronouncedly with higher concentrations. B, concentration-response curves of these three dihydropyridines fitted to normalized data reveal an IC50 value of 455, 34.0, and 3.24 nM for Nif, Nitr, and Nimo, respectively. Ba2+ (100 µM) was present throughout. Membrane potential ranged from –27 to –48 mV; control ACh-induced hyperpolarization was 18.3 ± 1.72 mV (n = 24; range 7.2–31); for other points, sample size n = 4 to 9.

 
We tested two other widely used dihydropyridines, nifedipine and nimodipine, to see whether and how they mimic nitrendipine in inhibiting ACh-induced hyperpolarization. We found that 10 µM nifedipine and 1 µM nimodipine suppressed the ACh-induced hyperpolarization by 83 ± 4.4 and 95 ± 6.6%, respectively (Figs. 4 and 5), which approximately mimicked the inhibition of 1 µM nitrendipine. The suppressive action of all the three DHPs reached the maximum in ~15 min during a "wash-in", but the wash-out recovery was notably different. The ACh-induced hyperpolarization often recovered to approximately 60% of the control after a 20-min wash with a drug-free Krebs' solution in the cases of nifedipine and nimodipine, but usually much less (e.g., 20%) recovery was achieved after a 60-min wash-out of nitrendipine, although the fast transient phase recovered faster. Therefore, when estimating the concentration-action relation in a single cell, we consecutively stepped up DHP concentration and used a 15-min wash-in time for each concentration applied. The Hill equation fit to normalized ACh-induced hyperpolarization amplitudes revealed that nimodipine, nitrendipine, and nifedipine had an IC50 value of 3.2, 34, and 455 nM, respectively (Fig. 4).

Effects of Non-DHP Ca2+ Channel Blockers on ACh-Induced Hyperpolarization. We previously demonstrated that ACh-induced hyperpolarization in the SMA is a Ca2+-dependent event (Jiang et al., 2005Go). To test whether the dihydropyridine inhibition of ACh-induced hyperpolarization was related to its blocking action on L-type Ca2+ channels, we observed effects of other classes of Ca2+ channel blockers on the ACh-induced hyperpolarization. Figure 5 depicts the main results. In contrast to nifedipine and other DHPs, the IL blockers 10 µM diltiazem, 100 µMCd2+, or the T-type Ca2+ channel blocker 100 µM Ni2+ caused no significant alteration of the ACh-induced hyperpolarization. Verapamil (10 µM), a blocker for IL, attenuated the ACh-induced hyperpolarization by 21 ± 3.9% (paired t test, p < 0.01; n = 6), which was a significantly weaker inhibition than that of 10 µM nifedipine (Student's t test, p < 0.05).

DHP Blocks ACh-Induced Vasoconstriction. ACh (1–3 µM for 2 min) induced a dilation in six of 10 SMA segments tested (to 58.8 ± 3.7 µm from a control of 56.4 ± 3.5 µmor increased by 4.3 ± 0.27% (paired t test, p < 0.05; n = 6; Fig. 6). The induced dilation was usually slow in its onset and offset, whereas it occasionally showed a fast transient dilation and/or contraction followed by a slow dilation. The quantitative measurement was done only on the peaks of slow-diameter changes that usually occurred approximately 2 min after the ACh application. DAMP (50 nM) completely blocked the ACh-induced dilation 10 min after its application (Fig. 6A). A partial recovery of the dilation was observed after 30-min wash-out, confirming that, like the ACh-induced hyperpolarization (Jiang et al., 2005Go), the dilation is an M3 receptor-mediated event. The ACh-induced dilation is also near completely suppressed by 50 nM ChTX or 1 µM nitrendipine in all vessels tested (n = 3 and 6, respectively; Fig. 6, B and C). The suppression was partially reversible. Nitrendipine, but not ChTX, alone caused a small dilation (1–3%) in three of five preparations. In the presence of ChTX or nitrendipine, a transient vasoconstriction was unmasked at the beginning of ACh application in most cases, consistent with an intracellular release of Ca2+ in muscle cells that triggered a contraction.


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The main finding of the present study is that nifedipine, nitrendipine, and nimodipine all concentration-dependently suppressed the ACh-induced hyperpolarization in the guinea pig inner ear artery via the blocking action on the IK channel. This is the first demonstration that the dihydropyridines, not the metal ions or other first generation Ca2+ antagonists diltiazem and verapamil, share the property of potently blocking the IK channel in vascular endothelial cells and thus suppressing the EDHF. Along with the main finding, we confirmed and extended a previous observation that, as in guinea pig submucosal arterioles (Coleman et al., 2001Go), IbTX failed to affect the EDHF-attributed hyperpolarization, supporting that the IK, not the BK, mediates the original hyperpolarization in the arteriolar endothelium. Furthermore, our demonstration of clotrimazole inhibition on the ACh-induced hyperpolarization extended the finding that clotrimazole derivatives triarylmethane-34 and triarylmethane-39 both block the IK and ACh-induced current in isolated rat carotid endothelial cells (Eichler et al., 2003Go). Therefore, IK mediation of the ACh-induced hyperpolarization in the vascular EC is probably across animal species and vascular beds.

IK Mediation of the ACh-Induced Hyperpolarization. Several lines of evidence from this and a previous study (Jiang et al., 2005Go) supported the notion that IK activation is largely responsible for the ACh-induced hyperpolarization in the endothelial cells. First, a combined application of 100 µM Ba2+ and 25 µM18betaGRA always almost completely suppresses the ACh-induced hyperpolarization in smooth muscle cells, but it does not affect it in endothelial cells, indicating the endothelial origin of the hyperpolarization (Jiang et al., 2005Go). Second, the hyperpolarization was associated with an increase in input conductance (decrease in input resistance); the amplitude of hyperpolarization was increased in cells with a less negative RP and decreased in cells with a more negative RP (Jiang et al., 2005Go), consistent with a K+ channel activation being responsible for the hyperpolarization (Hille, 2001Go). Third, the calmodulin antagonist trifluoperazine effectively suppressed the ACh-induced hyperpolarization (Fig. 2C), indicating that the responsible channel of the hyperpolarization belongs to the SK family, which requires calmodulin to function, not the BK, which does not require the calmodulin (Ledoux et al., 2006Go). Fourth, our immunohistochemical data demonstrated that IK proteins are clearly expressed in the EC of the SMA (Fig. 3). Finally and decisively, three classes of known IK channel blockers—ChTX, nitrendipine, and clotrimazole—suppressed the ACh-induced hyperpolarization, whereas BK blocker IbTX and other K+ channel blockers—Ba2+, glipizide, and 4-aminopyridine—had no significant effect.

Our data suggest that the small-conductance Ca2+-activated K+ channel plays a minor (~5%) role in generation of the ACh-induced hyperpolarization in the preparation used. The incomplete (81%) inhibition by 50 nM ChTX might simply be due to its less-than-sufficient concentration to reach a full block of IK, because the IC50 of the toxin was estimated to be ~30 nM for the IK in brain microvascular endothelial cells (Van Renterghem et al., 1995Go) and for the cloned human IK in HEK-293 cells (Jensen et al., 1998Go). The strong suppression by clotrimazole was probably not due to its inhibitory action on cytochrome P450 or voltage-gated K+ channels (Yuan et al., 1995Go; Eichler et al., 2003Go), since the ACh-induced hyperpolarization was not affected by 17-octadecynoic acid, a known cytochrome P450 inhibitor (Jiang et al., 2005Go). In addition, the estimated IC50 (116 nM) of clotrimazole is very close to that determined from HEK-293 cells that expressed human IK channels (153 nM; Jensen et al., 1998Go), and it is ~2-fold of that determined from the IK expressed in glioblastoma GL-15 cell lines (63 nM; Fioretti et al., 2004Go). Taken together, we have for the first time a quantitative estimation that IK activation is responsible for approximately 95% of the hyperpolarization induced by ACh in the endothelial cells.

IL Is Not Involved in DHP Inhibition on ACh-Induced Hyperpolarization. The ACh-induced Hyperpolarization is a Ca2+-dependent event, and the DHPs are well established L-type Ca2+ channel blockers. Our data demonstrated that the inhibition of ACh-induced hyperpolarization by the DHPs was not related to DHP antagonism on the IL channels. First, the known IL blockers diltiazem and Cd2+ showed no effect on the ACh-induced hyperpolarization. Verapamil caused 20% inhibition on the ACh-induced hyperpolarization; this could be related to its side action on other channels, rather than to its Ca2+ antagonism, since its inhibition on voltage-gated K+ channels and Na+ channels has been well documented (Lin et al., 1995Go; Yokoo et al., 1998Go). It is noteworthy that these data are consistent with a previous report that diltiazem and verapamil showed little inhibition on human IK channels expressed in HEK-293 cells (Jensen et al., 1998Go). Second, the potency of individual DHP in inhibiting ACh-induced hyperpolarization seems unrelated to its potency of IL inhibition. For example, the IC50 of nifedipine, nitrendipine, and nimodipine for IL was reported to be 36, 108, and 5.3 nM, respectively (Hermsmeyer et al., 1988Go; McCarthy and TanPiengco, 1992Go; Hirakawa et al., 1994Go), whereas it was 455, 34, and 3.2 nM for the IK inhibition (Fig. 4). The presently estimated IC50 of nitrendipine on the IK was very close to that determined on the cloned human IK expressed in HEK-293 cells (27 nM; Jensen et al., 1998Go). Our data are also consistent with a current belief that vascular endothelial cells do not express the voltage-gated Ca2+ channel, IL (Nilius and Droogmans, 2001Go; Ledoux et al., 2006Go).

It is interesting to note that the initial fast transient ACh-induced hyperpolarization was more resistant to all IK blockers used in this study than the delayed sustained hyperpolarization (Figs. 1, 2, 3). The transient hyperpolarization was rarely completely blocked by a high concentration of IK blockers, and its recovery during wash-out was long before the recovery of the sustained ACh-induced hyperpolarization. The cause of the apparent different sensitivity of the two phases to IK blockers remains to be found. It is noteworthy that ACh-induced increase in cytosolic calcium in the ECs often shows two phases, a fast transient phase followed by a slower sustained phase, very much corresponding to the two phases of hyperpolarization observed in the SMA and other arterioles (Nilius and Droogmans, 2001Go). There is evidence that the fast-phase elevation is mainly due to Ca2+ release from internal Ca2+ storage via the coupling between the M3 receptor and the inositol-1,4,5-triphosphate-sensitive mechanism (Fukao et al., 1997Go; Nilius and Droogmans, 2001Go) and that the second sustained phase relies on influx from the extracellular space, possibly via a store-operated Ca2+ channel, TRP channels, and other nonspecific cation channels (Nilius and Droogmans, 2001Go). We speculate that the different sources of Ca2+ may activate two distinct populations of IK channels that have different binding dynamics and/or accessibilities for the blockers.

Significance of DHP Blockade on IK-Mediated EDHF. A recent report verified that IK deficiency causes impaired EDHF and hypertension in a mouse model (Si et al., 2006Go). We found that 1 µM nitrendipine near completely suppressed the ACh-induced dilation (Fig. 6). Although it is possible that IL inhibition may also play a role, nitrendipine has a lower IC50 value for IK inhibition than that for IL inhibition; it is likely that its blocking action on IK, thus the hyperpolarization, may be primarily responsible for the inhibition of ACh-induced dilation.

In summary, the present study demonstrated that ACh-induced hyperpolarization in the SMA is mainly due to an activation of IK channels in the endothelial cells; dihydropyridines suppressed the ACh-induced hyperpolarization by blocking the IK with a potency order of nimodipine > nitrendipine > nifedipine. IK activation is a primary and essential step in EDHF-mediated hyperpolarization and vasodilation, and activation of the EDHF mechanism by ACh and other vasoactive agents may play an important role in keeping blood flow to vital organs in several clinical conditions. Therefore, clinicians should note that an administration of dihydropyridines might compromise the EDHF-mediated vasodilation in these patients.


    Acknowledgements
 
We thank Jill Lilly and Electra Allenton for reading the manuscript.


    Footnotes
 
This work was supported by grants from Deafness Research Foundation and National Institute on Deafness and Other Communication Disorders, National Institutes of Health Grant DC004716 (all to Z.-G.J.) and P30 05983.

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.106.115212.

ABBREVIATIONS: ACh, acetylcholine; EDHF, endothelium-derived hyperpolarization factor; SMC, smooth muscle cell; EC, endothelial cell; KCa, calcium-activated potassium channel; SMA, spiral modiolar artery; Kir, inward rectifier potassium channel; BK, big-conductance calcium-activated K+ channel; IK, intermediate-conductance Ca2+-activated K+ channel; SK, small-conductance Ca2+-activated K+ channel; HEK, human embryonic kidney; DHP, dihydropyridine; IL, L-type calcium current or channel; RP, resting potential; ChTX, charybdotoxin; CLT, clotrimazole; DAMP, 4-diphenylacetoxy-N-methylpiperidine methiodide; IbTX, iberiotoxin; TFP, trifluoperazine; 18betaGA, 18beta-glycyrrhetinic acid; PBS, phosphate-buffered saline; BSA, bovine serum albumin; SMC, smooth muscle cell; Nif, nifedipine.

Address correspondence to: Dr. Zhi-Gen Jiang, Oregon Hearing Research Center, NRC04, Oregon Health and Science University, Portland, OR 97239. E-mail: jiangz{at}ohsu.edu


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, and Weston AH (2002) EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374–380.[CrossRef][Medline]

Coleman HA, Tare M, and Parkington HC (2001) K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J Physiol (Lond) 531: 359–373.[Abstract/Free Full Text]

Eichler I, Wibawa J, Grgic I, Knorr A, Brakemeier S, Pries AR, Hoyer J, and Kohler R (2003) Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation. Br J Pharmacol 138: 594–601.[CrossRef][Medline]

Faraci FM and Heistad DD (1998) Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53–97.[Abstract/Free Full Text]

Fioretti B, Castigli E, Calzuola I, Harper AA, Franciolini F, and Catacuzzeno L (2004) NPPB block of the intermediate-conductance Ca2+-activated K+ channel. Eur J Pharmacol 497: 1–6.[CrossRef][Medline]

Fukao M, Hattori Y, Kanno M, Sakuma I, and Kitabatake A (1997) Sources of Ca2+ in relation to generation of acetylcholine-induced endothelium-dependent hyperpolarization in rat mesenteric artery. Br J Pharmacol 120: 1328–1334.[CrossRef][Medline]

Hermsmeyer K, Sturek M, and Rusch NJ (1988) Nitrendipine inhibition of calcium current in rat vascular muscle cells. J Cardiovasc Pharmacol 12: S100–S103.

Hille B (2001) Ionic Channels of Excitable Membranes. Sinauer Associates, Inc., Sunderland, MA.

Hirakawa Y, Kuga T, Kanaide H, and Takeshita A (1994) Actions of a new Ca2+ channel antagonist, CD832, on two types of Ca2+ channels in smooth muscle. Eur J Pharmacol 252: 267–274.[CrossRef][Medline]

Jensen BS, Strobaek D, Christophersen P, Jorgensen TD, Hansen C, Silahtaroglu A, Olesen SP, and Ahring PK (1998) Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol 275: C848–C856.

Jiang ZG, Nuttall AL, Zhao H, Dai CF, Guan BC, Si JQ, and Yang YQ (2005) Electrical coupling and release of K+ from endothelial cells co-mediate ACh-induced smooth muscle hyperpolarization in guinea-pig inner ear artery. J Physiol (Lond) 564: 475–487.[Abstract/Free Full Text]

Jiang Z-G, Qiu J-H, Ren T-Y, and Nuttall AL (1999) Membrane properties and the excitatory junction potentials in smooth muscle cells of cochlea spiral modiolar artery in guinea pigs. Hear Res 138: 171–180.[CrossRef][Medline]

Jiang Z-G, Shi XR, Zhao H, Si JQ, and Nuttall AL (2003) Basal nitric oxide production contributes to membrane potential and vasotone regulation of guinea pig in vitro spiral modiolar artery. Hear Res 189: 92–100.[CrossRef]

Jiang Z-G, Si J-Q, Lasarev MR, and Nuttall AL (2001) Two resting potential levels regulated by inward rectifying potassium channels in guinea pig cochlea spiral modiolar artery. J Physiol (Lond) 537: 829–842.[Abstract/Free Full Text]

Jiang ZG, Zhao H, and Yang YQ (2004) Distinct channels responsible for acetylcholine-induced hyperpolarization and depolarization in guinea pig in vitro spiral modiolar artery. Assoc Res Otolaryngol Midwint Res Meet Abstr 27: 996.

Konidala S and Gutterman DD (2004) Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovasc Dis 46: 349–373.[CrossRef][Medline]

Ledoux J, Werner ME, Brayden JE, and Nelson MT (2006) Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 21: 69–78.

Lin X, Hume RI, and Nuttall AL (1995) Dihydropyridines and verapamil inhibit voltage-dependent K+ current in isolated outer hair cells of the guinea pig. Hear Res 88: 36–46.[CrossRef][Medline]

McCarthy RT and TanPiengco PE (1992) Multiple types of high-threshold calcium channels in rabbit sensory neurons: high-affinity block of neuronal L-type by nimodipine. J Neurosci 12: 2225–2234.[Abstract]

Nilius B and Droogmans G (2001) Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415–1459.[Abstract/Free Full Text]

Si H, Heyken WT, Wolfle SE, Tysiac M, Schubert R, Grgic I, Vilianovich L, Giebing G, Maier T, Gross V, et al. (2006) Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 99: 537–544.[Abstract/Free Full Text]

Van Renterghem C, Vigne P, and Frelin C (1995) A charybdotoxin-sensitive, Ca(2+)-activated K+ channel with inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins. J Neurochem 65: 1274–1281.[Medline]

Yokoo H, Shiraishi S, Kobayashi H, Yanagita T, Yamamoto R, and Wada A (1998) Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells. Naunyn-Schmiedeberg's Arch Pharmacol 357: 526–531.[CrossRef][Medline]

Yuan XJ, Tod ML, Rubin LJ, and Blaustein MP (1995) Inhibition of cytochrome P-450 reduces voltage-gated K+ currents in pulmonary arterial myocytes. Am J Physiol 268: C259–C270.


This article has been cited by other articles:


Home page
Circ. Res.Home page
K. A. Dora, N. T. Gallagher, A. McNeish, and C. J. Garland
Modulation of Endothelial Cell KCa3.1 Channels During Endothelium-Derived Hyperpolarizing Factor Signaling in Mesenteric Resistance Arteries
Circ. Res., May 23, 2008; 102(10): 1247 - 1255.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Dietz, S. Du, C. W. Bolten, M. A. Payne, C. Xia, J. R. Blinn, J. W. Funder, and X. Hu
A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity
Hypertension, March 1, 2008; 51(3): 742 - 748.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.115212v1
320/2/544    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition